Page 406 - شرور شركات الأدوية

‫ﴍور ﴍﻛﺎت اﻷدوﻳﺔ‬

(58) Their delegation was led by Frank Wells: his textbook on fraud is
fantastic. I tell you this because you should understand that these are not
all bad people with inherently secretive natures.

(59) Sykes R. Being a modern pharmaceutical company. BMJ. 1998 Oct
31;317(7167):1172–80.

(60) http://www.bmj.com/content/339/bmj.b4330.
(61) De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et
al. Clinical trial registration: a statement from the International Committee
of Medical Journal Editors. The Lancet. 2004 Sep 11;364(9438):911-2.
(62) Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison
of Registered and Published Primary Outcomes in Randomized Controlled
Trials. JAMA. 2009 Sep 2;302(9):977–84.
(63) Wieseler B, McGauran N, Kaiser T. Still waiting for functional EU
Clinical Trials Register. BMJ. 2011 Jun 20;342(jun20 2):d3834-d3834.
(64) Prayle AP, Hurley MN, Smyth AR. Compliance with mandatory re-
porting of clinical trial results on ClinicalTrials.gov: cross sectional study.
BMJ. 2012;344:d7373.
(65) A good (but brief) overview of how to try and get info from non-
academic sources is here: Chan A-W. Out of sight but not out of mind: how
to search for unpublished clinical trial evidence. BMJ. 2012 Jan 3;344(jan03
2):d8013-d8013.
(66) You can read the letters and the report online. It’s a gripping
read, with many interesting and nefarious details, so I highly recommend
doing so: Medicines and Healthcare products Regulatory Agency (MHRA)
www.mhra.gov.u.GSK investigation concludes [Internet]. [cited 2012 Apr
29]. Available from: http://www.mhra.gov.uk/Howweregulate/Medicines/
Medicinesregulatorynews/CON014153.
(67) This was SmithKline Beecham, before they merged with GlaxoW-
ellcome and became GSK.

406